1. Home
  2. FCF vs NTLA Comparison

FCF vs NTLA Comparison

Compare FCF & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FCF
  • NTLA
  • Stock Information
  • Founded
  • FCF 1934
  • NTLA 2014
  • Country
  • FCF United States
  • NTLA United States
  • Employees
  • FCF N/A
  • NTLA N/A
  • Industry
  • FCF Major Banks
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • FCF Finance
  • NTLA Health Care
  • Exchange
  • FCF Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • FCF 1.7B
  • NTLA 1.4B
  • IPO Year
  • FCF N/A
  • NTLA 2016
  • Fundamental
  • Price
  • FCF $16.74
  • NTLA $12.16
  • Analyst Decision
  • FCF Hold
  • NTLA Buy
  • Analyst Count
  • FCF 5
  • NTLA 17
  • Target Price
  • FCF $17.70
  • NTLA $56.63
  • AVG Volume (30 Days)
  • FCF 525.5K
  • NTLA 2.4M
  • Earning Date
  • FCF 01-28-2025
  • NTLA 02-20-2025
  • Dividend Yield
  • FCF 3.11%
  • NTLA N/A
  • EPS Growth
  • FCF N/A
  • NTLA N/A
  • EPS
  • FCF 1.48
  • NTLA N/A
  • Revenue
  • FCF $456,467,000.00
  • NTLA $43,086,000.00
  • Revenue This Year
  • FCF N/A
  • NTLA $52.50
  • Revenue Next Year
  • FCF $2.11
  • NTLA $0.42
  • P/E Ratio
  • FCF $11.31
  • NTLA N/A
  • Revenue Growth
  • FCF 1.76
  • NTLA N/A
  • 52 Week Low
  • FCF $12.41
  • NTLA $11.34
  • 52 Week High
  • FCF $19.96
  • NTLA $34.87
  • Technical
  • Relative Strength Index (RSI)
  • FCF 35.20
  • NTLA 39.89
  • Support Level
  • FCF $16.69
  • NTLA $11.34
  • Resistance Level
  • FCF $17.14
  • NTLA $12.30
  • Average True Range (ATR)
  • FCF 0.49
  • NTLA 0.65
  • MACD
  • FCF -0.10
  • NTLA 0.05
  • Stochastic Oscillator
  • FCF 20.48
  • NTLA 35.26

About FCF First Commonwealth Financial Corporation

First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: